14-10-2025 16:11 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company Background
Piramal Pharma Ltd.
 
Industry : Pharmaceuticals & Drugs House : Private
BSE Code 543635
ISIN Demat INE0DK501011
Book Value 56.48
NSE Code PPLPHARMA
Dividend Yield % 0.07
Market Cap 255415.03
P/E 35.51
EPS 5.41
Face Value 10  
 
Incorporation Year 04-03 2020  
Registered Office Gr. Flr., Piramal Ananta,Agastya Corp. Park, Kamani Junction,Opp Fire Brigade,, L B S Marg, Kurla (West), Mumbai,
Maharashtra-400070 .
ISINNO INE0DK501011  
Phone 022 38023000 / 4000  
E-mail shareholders.ppl@piramal.com
URL www.piramalpharma.com
Industry Pharmaceuticals & Drugs  
Chairman Nandini Piramal  
Managing Director  
Company Secretary Tanya Sanish  
Listing BSE,NSE  
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.